Home/ Stocks/ OCUL

Ocular Therapeutix, Inc.

OCUL XNAS

$9.65 -0.35 (-3.64%) ▼ 15-min delayed

Open

$9.62

High

$9.72

Low

$9.30

Volume

2.10M

Market Cap

$2.11B

About Ocular Therapeutix, Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 325 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$10.79M	$-88,612,000	$-0.40
FY 2025	$51.95M	$-265,939,000	$-1.42
Q3 2025	$14.54M	$-69,418,000	$-0.38
Q2 2025	$13.46M	$-67,814,000	$-0.39

Earnings & Analyst Ratings

Next Earnings: Mon, Aug 3, 2026

Calendar →

Related Market News

No specific coverage for OCUL yet. Check out our latest market news or earnings calendar.

Get OCUL Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Ocular Therapeutix, Inc..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.